385114002: dispositif cutané (forme pharmaceutique)

SNOMED CT Concept\valeur de l'attribut\Pharmaceutical dose form (dose form)\forme transdermique (forme pharmaceutique)\Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Prolonged-release transdermal patch (dose form)	est un(e) (attribut)	Cutaneous AND/OR transdermal dosage form	false	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	est un(e) (attribut)	Drug patch (qualifier value)	false	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	Has dose form intended site (attribute)	Transdermal (intended site)	true	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	est un(e) (attribut)	forme transdermique (forme pharmaceutique)	true	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	Has dose form administration method (attribute)	Apply (administration method)	true	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	Has dose form transformation (attribute)	No transformation	true	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	Has dose form release characteristic (attribute)	Prolonged-release (release characteristic)	true	Inferred relationship	Some
Prolonged-release transdermal patch (dose form)	Has basic dose form (attribute)	Patch (basic dose form)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 1.04 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 1.56 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 2.5 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely ethinylestradiol 1.46 microgram/1 hour and norelgestromin 6.25 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 3.13 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 4.17 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 5.83 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 583 nanogram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Selegiline 500 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely oxybutynin 162 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Selegiline 375 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nicotine 458 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rivastigmine 192 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rivastigmine 396 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rotigotine 125 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rotigotine 41.667 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Buprenorphine 5 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely nicotine 1.563 milligram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely buprenorphine 15 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Capsaicin 179mg/hour transdermal patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Buprenorphine 20 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Buprenorphine 10 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Buprenorphine 5microgram/hour transdermal patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nicotine 11mg/24hours patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nicotine 22mg/day patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nitroglycerin 800 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nitroglycerin 200 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nitroglycerin 600 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 0.025mg/day patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 0.0375mg/day patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 0.05mg/day patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 0.075mg/day patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 0.1mg/day patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Scopolamine 0.5mg/24 hr patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 0.05mg/norethindrone acetate 0.25mg/day transdermal patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 14mcg/day transdermal patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Ethinyl estradiol 0.02mg / norelgestromin 0.15mg per day transdermal patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Fentanyl 12 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Selegiline 6mg/24hours transdermal patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Selegiline 9mg/24hours transdermal patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Selegiline 12mg/24hours transdermal patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rivastigmine 4.6mg/24 hours transdermal patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rivastigmine 9.5mg/24 hours transdermal patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 0.06mg/day transdermal patch (product)	a une forme pharmaceutique (attribut)	False	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 3.125 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 1.042 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 1.563 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 1.667 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rotigotine 83.333 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Estradiol 2.083 microgram/hour and norethindrone acetate 7.083 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Scopolamine 13.889 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Testosterone 104.167 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Buprenorphine 35 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nitroglycerin 208.333 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Testosterone 208.333 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nicotine 291.667 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely nicotine 312.5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nitroglycerin 416.667 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nicotine 583.333 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nitroglycerin 625 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Nicotine 625 microgram/hour prolonged-release transdermal patch	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely nicotine 875 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some
Product containing precisely nicotine 937.5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	a une forme pharmaceutique (attribut)	True	Prolonged-release transdermal patch (dose form)	Inferred relationship	Some

Reference Sets

Canada English language reference set (foundation metadata concept)

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3634738017	Prolonged-release transdermal patch (dose form)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3634739013	Prolonged-release transdermal patch	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
37211000188110	dispositif cutané	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
616661000241116	dispositif cutané (forme pharmaceutique)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)